Home › Funds › Artia Global Partners LP › MRNA
Artia Global Partners LP position in MRNA
MODERNA INC · Health Care
Artia Global Partners LP reported holding 20,000 shares of MRNA (MODERNA INC) in its Q3 2026 13F filing — a position valued at US$3.9M, representing 0.78% of its reported portfolio and ranking #31 among its reported holdings. Artia Global Partners LP has disclosed MRNA holdings in 3 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's MRNA position evolved
Artia Global Partners LP first disclosed a stake in MRNA in Q3 2025 at 23,800 shares (US$615K). The position peaked in Q1 2026 at 200,000 shares, worth US$10.2M. Across 3 filings, Artia Global Partners LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 20,000 shares valued at US$3.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 23.80K | $614.75K | New |
| Q1 2026 | 200.00K | $10.16M | New |
| Q3 2026 | 20.00K | $3.85M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MRNA and 13F data
MRNA (MODERNA INC) is a Health Care company. 45 other funds we track also report a position in MRNA — the largest reported positions include Fidelity Management & Research (FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford & Co (US$2.20B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MRNA
- Fidelity Management & Research (FMR) 58.96M sh · $11.35B · Q3 2026
- Capital World Investors 22.64M sh · $4.36B · Q3 2026
- Baillie Gifford & Co 11.44M sh · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M sh · $1.28B · Q3 2026
- IMC-Chicago, LLC 3.07M sh · $590.92M · Q3 2026
- Merck & Co., Inc. 2.31M sh · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M sh · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M sh · $324.39M · Q2 2026
- a16z Perennial Management, L.P. 1.52M sh · $292.57M · Q3 2026
- BAMCO INC /NY/ 1.39M sh · $267.88M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M sh · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M sh · $192.58M · Q3 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held MRNA?
Artia Global Partners LP has disclosed MRNA holdings in 3 of the last 5 reported quarters, going back to Q3 2025.
What is Artia Global Partners LP's current position in MRNA?
As of Q3 2026, Artia Global Partners LP holds 20.00K shares of MRNA (MODERNA INC), valued at $3.85M, representing 0.78% of its reported portfolio and ranking #31.
Has Artia Global Partners LP been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Artia Global Partners LP newly opened its position in MRNA. The position peaked in Q1 2026 at 200.00K shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include Fidelity Management & Research (FMR), Capital World Investors, Baillie Gifford & Co, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.